Cargando…
Preneoplastic Low-Risk Mammary Ductal Lesions (Atypical Ductal Hyperplasia and Ductal Carcinoma In Situ Spectrum): Current Status and Future Directions
SIMPLE SUMMARY: Overtreatment which means providing a patient with unnecessary medical intervention has recently become the center of attention in breast diseases. One of these lesions is low-risk ductal carcinoma in situ (DCIS), for which the standard of treatment is wide local excision/mastectomy,...
Autor principal: | Khoury, Thaer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833401/ https://www.ncbi.nlm.nih.gov/pubmed/35158775 http://dx.doi.org/10.3390/cancers14030507 |
Ejemplares similares
-
The diagnosis and management of pre-invasive breast disease: Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) – current definitions and classification
por: Pinder, Sarah E, et al.
Publicado: (2003) -
Diagnostic underestimation of atypical ductal hyperplasia and ductal
carcinoma in situ at percutaneous core needle and vacuum-assisted biopsies of
the breast in a Brazilian reference institution
por: Badan, Gustavo Machado, et al.
Publicado: (2016) -
Bilateral Atypical Ductal Hyperplasia with Microcalcifications in a Patient with Gynecomastia
por: Vidal, Pedro, et al.
Publicado: (2016) -
Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape
por: Kader, Tanjina, et al.
Publicado: (2018) -
Current approach and future perspective for ductal carcinoma in situ of the breast
por: Kanbayashi, Chizuko, et al.
Publicado: (2017)